Aminoglycosides: Difference between revisions
No edit summary |
|||
(2 intermediate revisions by one other user not shown) | |||
Line 6: | Line 6: | ||
**Bacterial [[endocarditis]] | **Bacterial [[endocarditis]] | ||
*Used +/- [[beta-lactam]] | *Used +/- [[beta-lactam]] | ||
*Nephro and oto | *Nephro and oto toxic. Risk of neuromuscular blockade. | ||
*Can precipitate crisis in patients with [[myasthenia gravis]] | *Can precipitate crisis in patients with [[myasthenia gravis]] | ||
*Include [[gentamicin]] and [[tobramycin]] | |||
==See Also== | ==See Also== | ||
Line 14: | Line 15: | ||
==References== | ==References== | ||
<references/> | <references/> | ||
{{Template:Clinically Utilized Antibiotics}} | {{Template:Clinically Utilized Antibiotics}} |
Latest revision as of 00:44, 10 July 2017
Background
- Used (alone or with beta-lactam) to treat serious infections due to gram-negative bacilli, e.g.:
- Ill patient with pyelonephritis
- Meningitis (due to pseudomonas, acinetobacter)
- Peritoneal dialysis-associated peritonitis
- Bacterial endocarditis
- Used +/- beta-lactam
- Nephro and oto toxic. Risk of neuromuscular blockade.
- Can precipitate crisis in patients with myasthenia gravis
- Include gentamicin and tobramycin
See Also
References
|